CpG motifs as possible adjuvants for the treatment of allergic diseases

International Archives of Allergy and Immunology

Volumn 129, Issue 3, 2002, Pages 198-203

  Bohle, Barbara ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

CpG motif; Immunomodulation; Specific immunotherapy; Th1 Th2; Type I allergy

Indexed keywords

ANTIGEN; CYTOSINE; DNA; GAMMA INTERFERON; GUANOSINE; INTERLEUKIN 12; OLIGODEOXYNUCLEOTIDE;

ALLERGIC DISEASE; DNA SEQUENCE; DOWN REGULATION; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOSTIMULATION; IMMUNOTHERAPY; MAMMAL; METHYLATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN SYNTHESIS; REVIEW; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CYTOKINES; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; OLIGODEOXYRIBONUCLEOTIDES; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0036438889     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066771     Document Type: Review

References (65)

1. Sparwasser T, Miethke T, Lipford G, Erdmann A, Hacker H, Heeg K, Wagner H: Macrophages sense pathogens via DNA motifs: Induction of tumor necrosis factor-alpha-mediated shock. Eur J Immunol 1997;27:1671-1679.
2. Sparwasser T, Koch ES, Vabulas RM, Heeg K, Lipford GB, Ellwart JW, Wagner H: Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 1998;28:2045-2054.
3. Hartmann G, Weiner GJ, Krieg AM: CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci USA 1999;96:9305-9310.
4. Bohle B, Jahn-Schmid B, Maurer D, Kraft D, Ebner C: Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic invidivuals and inhibit IgE synthesis in vitro. Eur J Immunol 1999;29:2344-2353.
5. Bauer M, Heeg K, Wagner H, Lipford GB: DNA activates human immune cells through a CpG sequence-dependent manner. Immunology 1999;97:699-705.
6. Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, Ballas ZK, Endres S, Krieg AM, Hartmann G: Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol 2001;31:2154-2163.
7. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klin-man DM: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995;374:546-549.
8. Liang H, Nishioka Y, Reich CF, Pisetsky DS, Lipsky PE: Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest 1996;98:1119-1129.
9. Ballas ZK, Rasmussen WL, Krieg AM: Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 1996;157:1840-1845.
10. Chace JH, Hooker NA, Mildenstein KL, Krieg AM, Cowdery JS: Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12. Clin Immunol Immunopathol 1997;84:185-193.
11. Noon L: Prophylactic inoculation against hay fever. Lancet 1911;i:1572-1573.
12. Akdis CA, Blaser K: IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: Two key steps in specific immunotherapy. FASEB J 1999;13:603-609.
13. Durham SR, Varney VA, Gaga M, Jacobson MR, Varga EM, Frew AJ, Kay AB: Grass pollen immunotherapy decreases the number of mast cells in the skin. Clin Exp Allergy 1999;29:1490-1496.
14. Secrist H, DeKruyff RH, Umetsu DT: Interleu-kin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med 1995;181:1081-1089.
15. Wagner H: Bacterial CpG DNA activates immune cells to signal infectious danger. Adv Immunol 1999;73:329-368.
16. Bird AP: Functions for DNA methylation in vertebrates. Cold Spring Harb Symp Quant Biol 1993;58:281-285.
17. Cross SH, Bird AP: CpG islands and genes. Curr Opin Genet Dev 1995;5:309-314.
18. Siegfried Z, Eden S, Mendelsohn M, Feng X, Tsuberi BZ, Cedar H: DNA methylation represses transcription in vivo. Nat Genet 1999;22:203-206.
19. Karlin S, Doerfler W, Cardon LR: Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? J Virol 1994;68:2889-2897.
20. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-745.
21. Takeshita F, Leifer CA, Gursel I, Ishii KJ, Takeshita S, Gursel M, Klinman DM: Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 2001;167:3555-3558.
22. Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S, Wagner H, Lipford GB: Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001;98:9237-9242.
23. Kirschning CJ, Bauer S: Toll-like receptors: Cellular signal transducers for exogenous molecular patterns causing immune responses. Int J Med Microbiol 2001;291:251-260.
24. Akira S, Takeda K, Kaisho T: Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675-680.
25. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A: The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000;97:13766-13771.
26. Ito T, Amakawa R, Kaisho T, Hemmi H, Tajima K, Uehira K, Ozaki Y, Tomizawa H, Akira S, Fukuhara S: Interferon-alpha and interleukin-12 are induced differentially by toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med 2002;195:1507-1512.
27. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G: Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002;168:4531-4537.
28. Hartmann G, Krieg AM: Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 2000;164:944-953.
29. Hartmann G, Weeratna RD, Ballas ZK, Payette P, Blackwell S, Suparto I, Rasmussen WL, Waldschmidt M, Sajuthi D, Purcell RH, Davis HL, Krieg AM: Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J Immunol 2000;164:1617-1624.
30. Verthelyi D, Ishii K, Gursel M, Takeshita F, Klinman D: Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J Immunol 2001;166:2372-2377.
31. Gursel M, Verthelyi D, Gursel I, Ishii KJ, Klinman DM: Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J Leukoc Biol 2002;71:813-820.
32. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S: Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-1204.
33. Teramoto T, Fukao T, Tashita H, Inoue R, Kaneko H, Takemura M, Kondo N: Serum IgE level is negatively correlated with the ability of peripheral mononuclear cells to produce interferon gamma (IFNgamma): Evidence of reduced expression of IFNgamma mRNA in atopic patients. Clin Exp Allergy 1998;28:74-82.
34. Horner AA, Widhopf GF, Burger JA, Taka-bayashi K, Cinman N, Ronaghy A, Spiegelberg HL, Raz E: Immunostimulatory DNA inhibits IL-4-dependent IgE synthesis by human B cells. J Allergy Clin Immunol 2001;108:417-423.
35. Parronchi P, Brugnolo F, Annunziato F, Manuelli C, Sampognaro S, Mavilia C, Romagnani S, Maggi E: Phosphorothioate oligodeoxynucleotides promote the in vitro development of human allergen-specific CD4+ T cells into Th1 effectors. J Immunol 1999;163:5946-5953.
36. Van Uden JH, Tran CH, Carson DA, Raz E: Type I interferon is required to mount an adaptive response to immunostimulatory DNA. Eur J Immunol 2001;31:3281-3290.
37. Rothenfusser S, Hornung V, Krug A, Towarowski A, Krieg AM, Endres S, Hartmann G: Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta. Eur J Immunol 2001;31:3525-3534.
38. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ: The nature of the principal type 1 interferon-producing cells in human blood. Science 1999;284:1835-1837.
39. Bauer M, Redecke V, Ellwart JW, Scherer B, Kremer JP, Wagner H, Lipford GB: Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells. J Immunol 2001;166:5000-5007.
40. Bufe A, Gehlhar K, Grage-Griebenow E, Ernst M: Atopic phenotype in children is associated with decreased virus-induced interferon-alpha release. Int Arch Allergy Immunol 2002;127:82-88.
41. Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, Piccinni MP, Macchia D, Maggi E, Del Prete G, Romagnani S: IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol 1992;149:2977-2983.
42. Demeure CE, Wu CY, Shu U, Schneider PV, Heusser C, Yssel H, Delespesse G: In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production. J Immunol 1994;152:4775-4782.
43. Wedderburn LR, O'Hehir RE, Hewitt CR, Lamb JR, Owen MJ: In vivo clonal dominance and limited T-cell receptor usage in human CD4+ T-cell recognition of house dust mite allergens. Proc Natl Acad Sci USA 1993;90:8214-8218.
44. Bohle B, Schwihla H, Hu HZ, Friedl-Hajek R, Sowka S, Ferreira F, Breiteneder H, Bruijnzeel-Koomen CA, de Weger RA, Mudde GC, Ebner C, Van Reijsen FC: Long-lived Th2 clones specific for seasonal and perennial allergens can be detected in blood and skin by their TCR-hypervariable regions. J Immunol 1998;160:2022-2027.
45. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, Sinigaglia F: Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997;185:825-831.
46. Rogge L, D'Ambrosio D, Biffi M, Penna G, Minetti LJ, Presky DH, Adorini L, Sinigaglia F: The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol 1998;161:6567-6574.
47. Yssel H, Fasler S, de Vries JE, de Waal Malefyt R: IL-12 transiently induces IFN-gamma transcription and protein synthesis in human CD4+ allergen-specific Th2 T cell clones. Int Immunol 1994;6:1091-1096.
48. Smits HH, van Rietschoten JG, Hilkens CM, Sayilir R, Stiekema F, Kapsenberg ML, Wie-renga EA: IL-12-induced reversal of human Th2 cells is accompanied by full restoration of IL-12 responsiveness and loss of GATA-3 expression. Eur J Immunol 2001;31:1055-1065.
49. Jahn-Schmid B, Wiedermann U, Bohle B, Repa A, Kraft D, Ebner C: Oligodeoxynucleo-tides containing CpG motifs modulate the allergic Th2 response of BALB/c mice to Bet v 1, the major birch pollen allergen. J Allergy Clin Immunol 1999;104:1015-1023.
50. Magone MT, Chan CC, Beck L, Whitcup SM, Raz E: Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis. Eur J Immunol 2000;30:1841-1850.
51. Tighe H, Takabayashi K, Schwartz D, Van Nest G, Tuck S, Eiden JJ, Kagey-Sobotka A, Creticos PS, Lichtenstein LM, Spiegelberg HL, Raz E: Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000;106:124-134.
52. Santeliz JV, Nest GV, Traquina P, Larsen E, Wills-Karp M: Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J Allergy Clin Immunol 2002;109:455-462.
53. Marshall JD, Abtahi S, Eiden JJ, Tuck S, Milley R, Haycock F, Reid MJ, Kagey-Sobotka A, Creticos PS, Lichtenstein LM, Van Nest G: Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy. J Allergy Clin Immunol 2001;108:191-197.
54. Spiegelberg HL, Raz E: DNA-based approaches to the treatment of allergies. Curr Opin Mol Ther 2002;4:64-71.
55. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL: Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240.
56. Lombardi G, Sidhu S, Batchelor R, Lechler R: Anergic T cells as suppressor cells in vitro. Science 1994;264:1587-1589.
57. Levings MK, Roncarolo MG: T-regulatory 1 cells: A novel subset of CD4 T cells with immunoregulatory properties. J Allergy Clin Immunol 2000;106:S109-S112.
58. Asseman C, Powrie F: Interleukin 10 is a growth factor for a population of regulatory T cells. Gut 1998;42:157-158.
59. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
60. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK: Type 1 T regulatory cells. Immunol Rev 2001;182:68-79.
61. Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J: Insect venom immunotherapy induces interleukin-10 production and a Th2- to Th1-shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997;27:1131-1139.
62. Akdis CA, Joss A, Akdis M, Faith A, Blaser K: A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J 2000;14:1666-1668.
63. Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S: Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 1996;97:1288-1296.
64. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG: IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001;166:5530-5539.
65. Horner AA, Widhopf GF, Burger JA, Takabayashi K, Cinman N, Ronaghy A, Spiegelberg HL, Raz E: Immunostimulatory DNA inhibits IL-4-dependent IgE synthesis by human B cells. J Allergy Clin Immunol 2001;108:417-423.